Precision Medicine

Stoke Completes Phase 3 Enrollment for Dravet Drug Zorevunersen
Management & Regulatory Stoke Completes Phase 3 Enrollment for Dravet Drug Zorevunersen

The landscape of genetic medicine is shifting rapidly as researchers move beyond merely managing the symptoms of chronic conditions to addressing the very foundations of biological dysfunction within the human body. Dravet syndrome represents one of the most challenging forms of epilepsy,

Genetic Study Questions the Bison Heritage of Beefalo
Research & Development Genetic Study Questions the Bison Heritage of Beefalo

The legendary image of the American bison as a symbol of the untamed wilderness has long been complicated by a history of hybridization that many ranchers and conservationists are only now beginning to fully quantify through advanced genomic sequencing. While the term Beefalo was once touted as a

UCLA Advances CAR-NKT Cell Therapy for Multiple Sclerosis
Research & Development UCLA Advances CAR-NKT Cell Therapy for Multiple Sclerosis

The traditional approach to managing chronic autoimmune conditions has long relied on suppressing the entire immune system, but a transformative breakthrough from researchers at UCLA is now steering the medical community toward a more precise, cell-based future. By securing a substantial seven

Scientists Create First Synthetic Cell from Nonliving Matter
Biotech & Bioprocessing Scientists Create First Synthetic Cell from Nonliving Matter

The realization of a functional cellular system assembled entirely from nonliving chemical constituents marks a definitive boundary crossing for modern science, signaling that life is no longer an inherited mystery but a programmable technology. This breakthrough centers on a project known as

How Has KC CARE Evolved to Meet Diverse Healthcare Needs?
Research & Development How Has KC CARE Evolved to Meet Diverse Healthcare Needs?

Providing equitable medical services to underserved populations remains one of the most significant challenges for urban metropolitan regions where insurance gaps and high costs often prevent families from receiving essential preventative treatments. KC CARE Health Center has navigated this complex

AI Identifies Molecular Signatures for Blood Clot Risk
Tech & Innovation AI Identifies Molecular Signatures for Blood Clot Risk

The silent threat of venous thrombosis often bypasses the most rigorous clinical filters, making the sudden onset of life-threatening blood clots one of the most frustrating puzzles in modern hematology. Currently, the landscape of cardiovascular medicine is undergoing a seismic shift as digital

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later